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Department of Physiology & Biophysics, State University of New York at Stony Brook, Stony Brook, New YorkABSTRACT Transmural heterogeneities in Na/K pump current (IP), transient outward K
þ-current (Ito), and Ca
2þ-current (ICaL)
play an important role in regulating electrical and contractile activities in the ventricular myocardium. Prior studies indicated
angiotensin II (A2) may determine the transmural gradient in Ito, but the effects of A2 on IP and ICaL were unknown. In this study,
myocytes were isolated from fivemuscle layers between epicardium and endocardium.We found amonotonic gradient in both Ip
and Ito, with the lowest currents in ENDO. When AT1Rs were inhibited, EPI currents were unaffected, but ENDO currents
increased, suggesting endogenous extracellular A2 inhibits both currents in ENDO. IP- and Ito-inhibition by A2 yielded essentially
the same K0.5 values, so they may both be regulated by the same mechanism. A2/AT1R-mediated inhibition of IP or Ito or stim-
ulation of ICaL persisted for hours in isolated myocytes, suggesting continuous autocrine secretion of A2 into a restricted diffusion
compartment, like the T-system. Detubulation brought EPI IP to its low ENDO value and eliminated A2 sensitivity, so the T-sys-
tem lumen may indeed be the restricted diffusion compartment. These studies showed that 33–50% of IP, 57–65% of Ito, and a
significant fraction of ICaL reside in T-tubule membranes where they are transmurally regulated by autocrine secretion of A2 into
the T-system lumen and activation of AT1Rs. Increased AT1R activation regulates each of these currents in a direction expected
to increase contractility. Endogenous A2 activation of AT1Rs increases monotonically from EPI to ENDO in a manner similar to
reported increases in passive tension when the ventricular chamber fills with blood. We therefore hypothesize load is the signal
that regulates A2-activation of AT1Rs, which create a contractile gradient that matches the gradient in load.INTRODUCTIONRegional heterogeneities in action potential morphology in
canine left ventricle have been reported for decades
(reviewed in Di Diego et al. (1)). These differences are
due to transmural differences in functional expression of
multiple membrane currents including the transient out-
ward potassium current (Ito) (2–4), L-type calcium current
(ICa,L) (5), and Na/K ATPase pump current (IP) (6). More-
over, previous studies (4) have shown Ito can be modulated
by extracellular angiotensin II (A2). But despite decades of
work, regional heterogeneities are incompletely under-
stood. In this article, we build upon previous work and
provide new data suggesting overall hypotheses on why
these regional heterogeneities exist and how they are
established.
As shown in the Results, Ito, IP, and ICaL appear to be regu-
lated in a sustained manner by A2. A2 is the primary
effector of the renin-angiotensin system (RAS) and has
been most extensively studied in the vasculature, where it
is a vasoconstrictor. A2 is known to be produced by and
secreted from the kidneys (reviewed in Zhuo et al. (7)).
However, there is also a local RAS in cardiac tissue (8),
and autocrine A2 activation of angiotensin II type 1 recep-
tors (AT1Rs) induces cardiac hypertrophy (9). Thus, A2
not only regulates systemic pressure, but also contributes
to the regulation of ventricular chamber pressure via struc-
tural remodeling (reviewed in Lijnen and Petrov (10)).Submitted October 7, 2013, and accepted for publication April 17, 2014.
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0006-3495/14/06/2364/11 $2.00The AT1R is a member of the family of seven trans-mem-
brane, G-protein-coupled receptors (11). Binding of A2 to
AT1Rs activates receptor signaling in two sequential phases.
During the first phase, the heterotrimeric G-proteins Gq and
Gi are activated. Their signaling cascades activate phospho-
kinase C, and inhibit phosphokinase A and phosphoinosi-
tide 3 kinase (PI3K). However, these responses are active
for just a few minutes (11) and are therefore not relevant
to the chronic A2 effects we have studied in isolated canine
myocytes. During the second phase of signaling, G-protein-
coupled receptor kinases (reviewed in Penela et al. (12))
phosphorylate the activated AT1Rs, which then bind with
b-Arrestins, ending the G-protein-mediated signaling phase.
The b-Arrestins bring the receptor to clathrin-coated pits for
endocytosis (reviewed in DeWire et al. (13)). In the case of
the AT1R, the interaction with b-Arrestins is strong and
internalization is relatively long in duration. The b-Arrest-
ins act as signal transduction scaffolds for internalized
AT1R/b-Arrestin complexes. In heart muscle, this scaffold
is known to bind directly with Akt and its phosphatase
PP2A, Raf-1, and extracellular signal-related kinase
ERK1/2, and indirectly with MEK1. Thus, a number of
pathways could potentially be activated once the receptor
is internalized.
Autocrine secretion of A2 by cardiac myocytes has been
shown to increase in response to myocardial stretch (9).
Moreover, in the canine left ventricle, there is a transmural
gradient in both diastolic stretch and systolic contraction
(14–16), with the greatest stretch and contraction in
ENDO. Lastly, as described in the Discussion, the currentshttp://dx.doi.org/10.1016/j.bpj.2014.04.042
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observations suggest that a transmural gradient in autocrine
A2 secretion may be generated by the transmural gradient in
stretch during chamber filling. Further, the gradient in A2
may generate transmural gradients in ICaL, Ito, and IP, which
create the gradient in contraction. One test of this hypothesis
is to determine whether the transmural gradient in AT1R
activation correlates with the transmural gradient in stretch.
Another test is to determine whether A2/AT1R values coher-
ently regulate ICaL, Ito, and IP in a manner to create the
observed transmural gradient in contraction. The main pur-
pose of this study was to investigate the transmural effects of
A2/AT1Rs on IP, Ito, and ICaL. However, there was also a
longstanding puzzle that needed to be understood if our
data were to be taken seriously.
The results presented here, as well as in earlier publica-
tions, indicate that A2 effects in the heart are through
extracellular binding to its receptor. The source of A2
appears to be autocrine secretion. The puzzle was that
while extracellular A2 would rapidly diffuse away from
isolated myocytes, we also observed A2 effects that persist
for many hours after myocyte isolation. This contradiction
could be resolved if A2 is continuously secreted into a
diffusionally restricted compartment, such as the lumen
of the transverse tubular system (T-system). We provide
both experimental data and theoretical calculations that
support the idea of persistent autocrine A2 secretion into
the T-system lumen, where it regulates ICaL, Ito, and IP in
T-system membranes.METHODS
Canine left ventricular myocyte isolation
Myocytes were acutely isolated from the left ventricle of adult mongrel
dogs. A modified Langendorf procedure was used, in which a wedge of
left ventricle was perfused through a coronary artery with 0.5 mg/mL
collagenase (Type 2 collagenase; Worthington Biochemical, Lakewood
Township, NJ) and 0.08 mg/mL protease (Type XVI protease; Sigma,
St. Louis, MO). Perfusion lasted for 12–15 min followed by tissue mincing
(6,17). In most experiments, cells were obtained from five distinct transmu-
ral layers (EPI, EPI-MID, CENTER-MID, ENDO-MID, and ENDO), to
expand upon a previous study (6). Cell groups from each layer were sepa-
rately stored at room temperature (22–25C) in KB (Kraft Bru¨he) solution
containing 83 mM KCl, 30 mMK2HPO4, 5 mMMgSO4, 5 mMNa-pyruvic
acid, 5 mM b-OH-butyric acid, 5 mM creatine, 20 mM taurine, 10 mM
glucose, 0.5 mM EGTA, 2 mMKOH, and 5 mMNa2-ATP (pH¼ 7.2). Cells
were kept in KB solution for the duration of the experiments, which lasted
up to 24 h postisolation. For the in situ delivery of A2 study shown in
Fig. S4 of the Supporting Material, 5 mMA2 was delivered at 37C through
the coronary artery for 1 h before collagenase/protease digestion; cells were
studied immediately after digestion.
FIGURE 1 A transmural gradient in the Na/K ATPase current IP due to
AT1R receptor activation. (A) Representative trace of IP from a whole-
cell patch-clamp recording. Strophanthidin (Str), a specific inhibitor of
the Na/K ATPase, was used to block and quantify IP. (B) Application of
5 mM A2 made IP the same everywhere at the low ENDO level (lower
dashed line), whereas Sar, an inhibitor of the AT1R, made IP the same
everywhere at its high EPI level (upper dashed line). Significance is
denoted by the asterisk (*) (P < 0.05).Cell preparation
Some cell groups were incubated in KB solution at room temperature in the
presence of either A2 (10 nM to 5 mM) or the AT1R inhibitor saralasin
(2 mM) and compared with untreated control groups. Incubations with A2
or saralasin lasted 2–24 h.Cell detubulation
Cells were detubulated with the following procedure: After 1 h of incuba-
tion in KB solution, cells were transferred to a detubulation solution
containing 113 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM Na2HPO4,
20 mM Na-Acetate, 10 mM glucose, and 10 mM HEPES (pH ¼ 7.4
adjusted with NaOH). Then, detubulation was induced by osmotic shock
as described by Brette et al. (18). In brief, cells were first exposed to detu-
bulation solution containing 1.5 M formamide for 15–20 min. Detubulation
was induced by osmotic shock when cells were returned to detubulation
solution without formamide. After another 10–15 min in detubulation solu-
tion, cells were transferred to KB solution before experimentation.Electrophysiological recordings
IP and Ito were measured using the whole-cell patch-clamp technique at
room temperature. For IP recordings, the internal pipette solution contained
70 mM Na-aspartic acid, 20 mM K-aspartic acid, 30 mM CsOH, 20 mM
TEA Cl (tetraethylammonium chloride), 7 mM MgSO4, 5 mM HEPES,
11 mM EGTA, 1 mM CaCl2, 10 mM glucose, and 5 mM Na2-ATP
(pH ¼ 7.2 adjusted with CsOH). Pipette resistances were 2–3 MU before
sealing. During patch-clamp recording, cells were perfused with an external
solution containing 137.7 mMNaCl, 2.3 mMNaOH, 1 mMMgCl2, 5.4 mM
KCl, 10 mM glucose, 5 mM HEPES, 2 mM BaCl2, and 1 mM CdCl2 (pH¼
7.4 adjusted with NaOH). In whole-cell mode, cells were held at 0 mVand
IP was measured as the drop in whole-cell current upon introduction of a
saturating concentration of strophanthidin (0.5 mM) into the external solu-
tion (Fig. 1 A).
For Ito recordings, the pipette solution contained 95 mM K-aspartic acid,
11 mMEGTA, 15 mMKCl, 10 mM glucose, 10 mMHEPES, 30 mMKOH,
and 3 mM Mg-ATP (pH ¼ 7.2 adjusted with KOH). The external solution
contained 137.7 mM NaCl, 2.3 mM NaOH, 1 mM MgCl2, 5.4 mM KCl,
10 mM glucose, 5 mM HEPES, 2 mM MnCl2, and 1 mM CdCl2 (pH ¼ 7.4
adjusted with NaOH). A quantity of 100 mM tetrodoxin (TTX) or 3 mM
4-AP was added to the external solution in some experiments. Ito was
measured in response to 400-ms test potentials ranging from 50 to
þ50 mV from a holding potential of 60 mV in the presence of TTX. Peak
Ito was measured as the difference between peak current and current at the
end of the 400-ms test pulse. The accuracy of this protocol in measuring
pure Ito was confirmed by comparing measured Ito with the current trace
inhibited by 4-AP. In some experiments, instead of using TTX, a 10-ms pre-
pulse to 0 mV was applied to deactivate INa.
For ICaL recordings, other currents were minimized by setting the con-
centrations of intracellular Naþ and Kþ to zero by replacement withBiophysical Journal 106(11) 2364–2374
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concentrations of external Naþ and Kþ were also set to zero by replacement
with cesium Cl (6 mM) and TEACl (140 mM). We added 10 mM ryanodine
to block Ca2þ release from the sarcoplasmic reticulum, and 20 mM ouabain
to block IP, if any. At a holding potential of50 mV, ICaTwas inactivated so
that the currents represent only ICaL.
Whole-cell currents were recorded using an Axopatch-1D Patch-Clamp
Amplifier (Axon Instruments, Molecular Devices, Sunnyvale, CA) that
was interfaced to a computer with a DigiData 1200 Digitizer and the soft-
ware PCLAMP Ver. 8.2 (both by Axon Instruments, Molecular Devices).
Current measurements were normalized by the cell capacitance (Cm), which
was measured in each cell using the PCLAMP Membrane Test function.Data analysis and statistics
Voltage-clamp data were analyzed using the softwares CLAMPFIT, Ver. 8.2
(Axon Instruments, Molecular Devices), Microsoft EXCEL (Microsoft,
Redmond, WA), and SIGMAPLOT (Systat Software, St. Jose, CA).
Membrane currents are herein displayed as current densities (current
amplitude normalized by Cm, pA/pF), unless the term ‘‘amplitude’’ is
used to indicate an un-normalized current value. Pooled results, having
sample size n, are expressed as mean 5 SD. Differences between groups
were assessed with the Student’s t-test.FIGURE 2 Possible mechanisms of A2/AT1R regulation of IP. (A) An A2
dose-inhibition curve established by measuring IP from EPI cells incubated
in [A2]. Maximum inhibition was 37% and K0.5 was 185 nM. (B) IP was
maximally inhibited in all five layers with exogenous A2 and compared
to endogenous IP. (C) Percentages of maximum inhibition of IP by endog-
enous A2 activating AT1Rs in the corresponding layers. (D) Endogenous
[A2] was predicted from the inhibitions in panel B based on the dose-inhi-
bition relationship in panel A.RESULTS
Transmural gradients in the effects of
endogenous [A2] on IP and Ito
Fig. 1 A shows a typical whole-cell patch-clamp recording
of the Na/K ATPase pump current (IP) from an isolated
canine ventricular myocyte. In each cycle, the Na/K
ATPase translocates 3 Naþ out of and 2 Kþ into the cell,
so there is a net outward current IP. External application
of a saturating concentration of strophanthidin, a specific in-
hibitor of the Na/K ATPase, blocks the outward current and
causes the holding current to shift inward by an amount
equal to the maximum value of IP. Similar experiments
done in myocytes isolated from EPI and ENDO regions of
the ventricular wall show a transmural gradient in maximum
IP (Fig. 1 B), consistent with previously reported data (6). To
determine whether A2 and AT1Rs might be involved, a satu-
rating concentration of exogenous A2 or a saturating con-
centration of the AT1R antagonist saralasin were used on
EPI and ENDOmyocytes. Fig. 1 B shows that 2 h incubation
with 5 mM A2 inhibited IP in EPI to ENDO levels, but did
not significantly affect IP in ENDO (lower dashed line). In
contrast, 2 h incubation with 2 mM saralasin increased IP
in ENDO to EPI levels (upper dashed line), but did not
significantly affect IP in EPI.
These data suggest:
1. Na/K ATPase protein is uniform across the ventricular
wall; and
2. IP is transmurally regulated through autocrine secretion
of endogenous A2 and activation of AT1Rs.
These data do not indicate, however, whether it is a transmu-
ral gradient in the sensitivity of the AT1Rs with a uniform
endogenous A2, or a transmural gradient in endogenousBiophysical Journal 106(11) 2364–2374A2 with uniform AT1R properties. These two models are
described and investigated below.
Model 1
Model 1 is that [A2] is uniform but there are two types of
receptors—one with a high affinity for A2, so these would
always be essentially saturated, and the other with a low
affinity for A2, so these would always be essentially inac-
tive. There could be a transmural gradient from all high-
affinity receptors in ENDO to all low-affinity receptors
in EPI, possibly through posttranslational modifications of
the receptors in response to the transmural gradient in strain.
Model 2
Model 2 is that all affected receptors are the same, but there
is a transmural gradient in autocrine A2 secretion, possibly
in response to the transmural gradient in strain.
Although the data in Fig. 2 do not distinguish between
these two models, the interpretation of each panel would
be quite different, depending on which model is correct..
EPI myocytes were used to construct an exogenous [A2]
dose-inhibition curve for IP (Fig. 2 A). Based on the
curve-fit, we calculated the maximal IP inhibition by A2
to be 37% with an effective K0.5 of 185 nM. The K0.5 would
represent the low-affinity type receptors in Model 1, or
it would represent all involved receptors in Model 2.
We next determined the fraction of A2/AT1R-mediated inhi-
bition of IP in each of the five transmural layers. Cells from
Autocrine A2 CreatesTransmural Gradients 2367each layer were incubated with external A2 at a saturating
concentration (5 mM) and external A2-induced inhibition
of IP was documented for each layer (Fig. 2 B). The trans-
mural percentages of maximum inhibition are shown in
Fig. 2 C. This would be close to the percentage of high-
affinity receptors in Model 1. To derive transmural concen-
trations of endogenous A2 predicted by Model 2, the
concentrations of A2 were back-calculated from the dose-
inhibition relationship in Fig. 2 A given the inhibitions
shown in Fig. 2 B.
Yu et al. (4) reported Ito in ENDO could be increased to
EPI values by incubating ENDO cells with the AT1R antag-
onist losartan, and Ito in EPI could be reduced to ENDO
values by incubating EPI cells with saturating A2. These ob-
servations suggest that the transmural gradient in Ito, like the
gradient in IP, is due to a transmural gradient in A2/AT1Rs.
Similar to our observations using IP, we also observed a
transmural gradient in Ito (Fig. 3, A and B). The current
increased continuously and monotonically from a value of
4 pA/pF in ENDO to a maximum of 13 pA/pF in EPI.
The maximum increase in Ito was therefore ~69%, con-
sistent with Yu et al. (4). The voltage dependence of ItoFIGURE 3 A transmural gradient in Ito. (A) Representative traces of out-
ward currents from five transmural layers. (B) Peak Ito current-voltage
relationships exhibit a transmural gradient in Ito magnitude at test potentials
>20 mV. (C) The Ito gradient can be attributed to changes in the amplitude
and not the voltage dependence of Ito. (D) A2 does not shift the voltage
dependence but only affects the amplitude of Ito.was essentially the same in each transmural layer, based
on Ito values relative to Ito in EPI at every test potential
(Fig. 3 C). This suggests the number of functional Ito
channels is different in each layer. The voltage depen-
dence of Ito was also not affected by A2, because the ratio
of Ito(EPIþA2)/Ito(EPI) was the same at each voltage
(Fig. 3 D). These observations are consistent with:
1. Ito protein is uniform across the ventricular wall; and
2. Ito is transmurally regulated through autocrine secretion
of endogenous A2 and activation of AT1Rs.
As was done for IP, EPI myocytes were used to construct
an [A2] dose-inhibition curve for Ito (Fig. 4 A). The curve-fit
yielded a maximal inhibition of 56% and a K0.5 of 169 nM.
The dose-inhibition curve of IP is also plotted (Fig. 4 A) to
illustrate the similarity of the two curves. Inhibition by
exogenous A2 was recorded at five locations across the ven-
tricular wall (Fig. 4 B). The percentage of maximum inhibi-
tion was calculated (Fig. 4 C). These data are very similar to
the data in Fig. 2 C, so the same transmural gradient in either
high-affinity AT1Rs or endogenous A2 appears to regulate
both Ito and IP. Predicted values of endogenous [A2] were
back-calculated from the dose-inhibition curve of Ito inFIGURE 4 Possible mechanisms of A2/AT1R regulation of Ito. (A) An
A2 dose-inhibition curve was constructed by measuring Ito from EPI cells
incubated in [A2]. Maximum inhibition was 56% and K0.5 was 169 nM.
The dose-inhibition curve based on IP is overplotted. (B) Ito was maximally
inhibited in all five layers with saturating A2 and compared to endogenous
Ito. (C) Percentages of maximum inhibition of Ito by endogenous A2
activating AT1Rs in the corresponding layers. (D) Endogenous [A2] was
predicted from the inhibitions in panel B based on the dose-inhibition rela-
tionship in panel A.
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FIGURE 5 EPI and ENDO differences in T-system IP. (A) In detubulated
cells (Detub), cell capacitance (Cm) declined 28% in EPI. T-system (T-Tub)
membrane capacitance, and hence the membrane area, was calculated to be
the difference between Con and Detub Cm. (B) Cm decreased by 23% in
ENDO. T-Tub membrane capacitance was calculated as in panel A. (C) De-
tubulation caused a significant decrease in EPI IP amplitude. Taking the dif-
ference between Con and Detub IP amplitudes yielded T-Tub IP amplitude.
(D) Detubulation minimally decreased ENDO IP amplitude. T-Tub IP was
calculated as in panel C. (E and F) IP membrane density for total cell
(Con), cell surface (Detub), and T-Tub were calculated by dividing the IP
amplitude by the corresponding Cm. The density of IP in T-system mem-
branes appears to be much higher than that in surface cell membrane, but
in ENDO most of T-system IP is inhibited by endogenous A2.
2368 Gao et al.Fig. 4 A and the inhibitions in Fig. 4 B. The values are
graphed in Fig. 4 D where they are compared to the concen-
trations of A2 predicted from IP data. Based on the similarity
of concentrations derived from Ito to the values obtained
with IP, if Model 2 is correct, the same transmural gradient
in A2 regulates both IP and Ito. The smooth curve-fit through
these points is based on a simple relationship between
myocardial strain and position in the ventricular wall, pro-
vided in the Discussion (see Corollary 4: A2 is Secreted
in Response to Load and Causes Increased Contractility).
Based on the above results, there is no compelling reason
to choose between Model 1 and Model 2. However, there are
other data showing increases in autocrine secretion of A2 by
cardiac myocytes subjected to stretch (9), so these data pro-
vide some support for Model 2. Moreover, if Model 1 is cor-
rect and there are two types of AT1Rs, they might run
differently on Western blots. Fig. S1 shows Western blots
of AT1Rs from EPI and ENDO recorded in cells from
both left and right ventricles, and there is no difference.
Thus, we found no data to support Model 1, and there are
data to support Model 2. Our working hypothesis is that
the transmural gradient in [A2], shown in Fig. 4 C, is
responsible for the transmural gradients in ion transport.
Another area of investigation concerns the mechanism by
which AT1R-activation signals reductions in both IP and Ito.
It was previously shown that Kv4.3, the a-subunit of Ito,
serves as a co-immunoprecipitator with the AT1R and is
internalized with receptor activation and internalization
(19). Fig. S2 shows that the a1-subunit of IP also co-immu-
noprecipitates with the AT1R in ventricular myocytes.
Moreover, inhibiting trafficking by disruption of microtu-
bules eliminates the inhibitory effect of AT1R activation
on both IP and Ito (20,21). These data suggest that AT1Rs
are associated with IP and Ito protein, such that activation
and internalization of AT1Rs carries IP and Ito protein along
with the receptor and reduces the totality of functional trans-
porters in the plasma membrane.Localization of A2 effects in the T-system
Even though the cells were isolated, and secreted molecules
should diffuse away, effects of endogenous A2 were seen to
persist for hours. This is consistent with continuous renewal
into a restricted diffusion space. The existence of T-tubules
in cardiac myocytes has been well documented, and the
lumen of the T-system certainly could allow a relatively
high concentration of A2 to be sequestered. We therefore
tested whether A2-dependent reductions of IP are dependent
on the presence of the T-system.
Isolated EPI and ENDO cells were detubulated using
formamide shock (22). Detubulation was indicated by a
decrease in Cm of 28% in EPI myocytes (Fig. 5 A) and
23% in ENDO myocytes (Fig. 5 B). The T-system mem-
brane capacitance was calculated as the difference between
control and detubulated myocytes (EPI: 59 pF; ENDO:Biophysical Journal 106(11) 2364–237447 pF). These results indicate that ~25% of the cell’s surface
membrane resides in the T-system, a result consistent with
electron microscopy literature (23,24). When EPI myocytes
were detubulated, the amplitude of IP was reduced to essen-
tially the same value as that of ENDO (Fig. 5 C). Whereas,
when ENDO myocytes were detubulated, IP amplitude was
minimally reduced (Fig. 5 D). Based on these results, the
T-system IP amplitude in ENDO was calculated to be just
3 pA, implying that most of IP in the ENDO T-system is in-
hibited by endogenous A2 activating AT1Rs. Conversely,
EPI IP amplitude dramatically decreased in detubulated cells
(Fig. 5 C), although the change in Cm was comparable to
that of ENDO. EPI IP amplitude in the T-system was calcu-
lated to be 54 pA, which was much larger than that in the
T-system of ENDO. These results suggest the absence of
endogenous A2 effects results in high IP in EPI T-system
membranes.
To determine the density of IP in the total cell (control
myocytes) in the cell surface (detubulated myocytes) and
in the T-system membranes (Fig. 5, E and F), the IP ampli-
tudes were divided by the corresponding Cm values. These
FIGURE 7 The L-Type Ca2þ-current (ICaL) is transmurally regulated by
A2 through two sequential phases of AT1R activation. (A) The protocol for
measuring the time dependence of ICaL at a series of different voltages in a
cell from EPI and ENDO. (B) There is a transmural gradient in the peak
inward ICaL, with the value in ENDO being ~70% larger than that in EPI.
(C) Upon application of A2 to an EPI myocyte, the acute response is a
decrease in peak inward ICaL. This appears to be due to the G-protein-medi-
ated initial phase of AT1R signaling. (D) A summary of the effects of A2 on
ICaL in EPI myocytes. The initial response over the first 5 min is a 35%
decrease, which could be mimicked by application of the PI3K inhibitor
PI-103. After 2 h, the G-protein phase of AT1R activation has ended, the
receptor has internalized with b-arrestins to form a signal transduction scaf-
fold that activates a number of different pathways, resulting in a 70% in-
crease in peak inward I .
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significantly different between EPI and ENDO myocytes,
but that T-system IP amplitude is dramatically higher in
EPI. Therefore, the difference in IP amplitude between
EPI and ENDO (and hence the difference in autocrine A2
effects) can be attributed to the T-system membrane and
not to the cell surface membrane.
EPI myocytes were detubulated then incubated in the
presence of high exogenous [A2]. The Cm value was
reduced by detubulation but was essentially unaffected by
A2 (Fig. 6 A). Conversely, in EPI myocytes, IP could be
significantly reduced by either detubulation or exogenous
A2 (Fig. 6 B). However, application of A2 to detubulated
EPI myocytes did not affect IP amplitude (Fig. 6 B), indi-
cating that autocrine A2 effects are localized to membranes
lining the T-system lumen.
The detubulation data imply endogenous [A2] does not
decrease due to diffusion away from isolated myocytes
because it is continuously secreted into a small restricted
compartment, the T-system lumen (see Corollary 2: A
Transmural Gradient in A2).
However, one expects A2 secretion to eventually run
down. Fig. S3 shows that this is indeed the case, and IP in
isolated ENDO myocytes increases to EPI levels over a
period of 28–29 h, whereas IP in EPI does not change. At
the end of this time period, addition of 5 mM exogenous
A2 caused IP in ENDO to return to its original low value.
This is consistent with the idea of a transmural gradient in
A2 secretion eventually running down.CaLA transmural gradient in ICaL is regulated by
endogenous A2
Wang and Cohen (5) first demonstrated ICaL was signifi-
cantly higher in ENDO than EPI. Fig. 7 shows ICaL data re-
corded from ENDO and EPI and also shows the effect of
exogenous A2 on the gradient. Moreover, in the Introduc-
tion, we described what is known about AT1R signaling,
which occurs in two sequential phases. Fig. 7 also shows
two sequential phases of effects of A2 on ICaL. Note thatFIGURE 6 Summary of exogenous A2 effects in EPI control (Con) and
detubulated (Det) myocytes. (A) Cm decreased similarly upon detubulation
in both Con and A2 myocytes. (B) In Con myocytes, application of A2
induced a significant decrease in IP amplitude but had no effect in Det
myocytes. These results suggest that A2/AT1R effects on IP mostly take
place in the T-system.G-protein-mediated signaling leads initially to inhibition.
However, after 2 h of incubation with A2, internalization
of receptors leads to increased ICaL. Because all of our other
data were recorded after 2 h of incubation in either A2 or an
AT1R inhibitor, Fig. 7 suggests these other data also show
effects of receptor internalization.
Fig. 7 A shows the time dependence of a typical set
of calcium currents measured from ENDO and EPI myo-
cytes. Averages of the inward currents are graphed as a
function of voltage in Fig. 7 B, where the peak inward cur-
rent in ENDO is ~1.7 pA/pF, but that in EPI is ~1 pA/pF,
indicating a significant transmural gradient. These data
represent the steady-state conditions in ENDO and EPI.
Similar results were initially published by Wang and
Cohen (5), but they did not investigate the mechanism of
regulation.
Fig. 7 C shows the short-term, transient effect of A2 on
ICaL in an EPI myocyte. The protocol was the same as shown
in Fig. 7 A; peak inward current is graphed versus time. Over
a period of ~5 min, ICaL is reduced on average by 35%
(Fig. 7 D). The PI3K inhibitor, PI-103, caused a similar
decrease in ICaL (Fig. 7 D). The short-term A2 response is
possibly through the canonical signaling pathway in which
Gq inhibits PI3K. When A2 was removed from the bathingBiophysical Journal 106(11) 2364–2374
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the patch lasted (Fig. 7 C).
Exposure to A2 for 2 h caused stimulation of ICaL.
Fig. 7 D shows the average effects of the various interven-
tions. When EPI was exposed to A2 for 2 h, peak inward
ICaL increased by ~70% to a value very similar to that in
ENDO. This increase is thought to be through signaling
by the internalized AT1R/b-Arrestin complex (reviewed
in the Introduction). The AT1R/b-Arrestin complex termi-
nates G-protein signaling by the AT1R and initiates a
number of new signal transduction cascades. Fig. 7 D
also shows that either short-term exposure to A2 or
direct inhibition of PI3K with the inhibitor PI-103 causes
an ~35% decrease in ICaL in EPI. This outcome is consis-
tent with the AT1R canonical pathway of Gq activation,
which inhibits PI3K, causing the initial inhibition of ICaL.
Long-term (2 h) incubation with A2 causes ICaL to in-
crease, which is in the opposite direction to the long-
term effects on IP and Ito, but the changes in all three
transporters are in the direction to increase contractility
in ENDO over EPI.In situ effects of A2 on the transmural
gradient in IP
All of the above experiments considered the effects of 2 h
incubation with A2 in isolated myocytes at room tempera-
ture. Fig. S4 shows A2 inhibits the transmural gradient in
IP when delivery is through the vasculature to a chunk of
canine heart tissue maintained at 37C. Fig. 7 A shows
that IP in EPI and ENDO is the same when 5 mMA2 is deliv-
ered through the vasculature for ~1 h before the whole-cell
patch-clamp study. Fig. 7 B shows the usual transmural
gradient in IP is present when this protocol is employed
without exogenous A2.DISCUSSION
The data presented here, in connection with previous
studies, suggest the following hypotheses, which unify a
number of observations:
1. Canine ventricular myocytes express an autocrine
RAS that is localized to the transverse tubular system
(T-system).
2. There is normally a transmural gradient in the effects of
[A2], with the effects in ENDO being highest.
3. Increases in [A2] coherently reduce Ito and IP, and in-
crease ICaL.
4. This autocrine RAS modifies A2/AT1R interaction in
response to load, and the consequent reductions in Ito
and IP and increase in ICaL all increase contractility.
5. The total number of transport proteins responsible for
either Ito or IP is uniform across the ventricular wall,
but those localized to T-system membranes can beBiophysical Journal 106(11) 2364–2374reversibly internalized with activated AT1Rs to create
the transmural gradients.
The corollary to Hypothesis 5 is that the transmural gradient
in KChIP2 is not related to the transmural gradient in Ito.
These are presented as working hypotheses that are consis-
tent with available data, as discussed below.Hypothesis 1: an autocrine RAS in the T-system
The presence of an autocrine RAS in ventricular myocytes is
supported by several studies. Pan et al. (25) demonstrated
message for the RAS components renin, angiotensinogen,
angiotensinogen-converting enzyme, and the AT1R in
canine ventricular myocytes. Sadoshima and Izumo (9)
stretched neonatal cardiac myocytes in vitro and observed
acute A2 secretion that resulted in the hypertrophic
response, which was inhibited in the presence of AT1R
antagonists. In this study, both IP and Ito were inhibited by
a saturating concentration of exogenous A2 or increased
by AT1R inhibition using saralasin or losartan (4), consistent
with the presence of endogenous A2 and AT1Rs.
The T-system seemed the logical place for an autocrine
RAS, based on several observations: A2 in cardiac tissue
is largely obtained via self-production (8), where its half-
life is 15–30 min, in contrast to 30 s in circulation (26).
Based on our IP and Ito measurements, effects of endogenous
A2 were essentially unchanged for hours in the isolated
ENDO myocytes. Persistent autocrine A2 effects without
immediate rundown could be explained if continuous secre-
tion occurred into a small restricted compartment like the
T-system lumen.
Our detubulization studies directly support the above
conclusion. In mammalian species, T-tubular membrane
makes up a significant percentage of the total membrane
area that contacts the extracellular environment, with values
of 39.6% in guinea pig left ventricle (LV) (23) and 32.6% in
the rat LV (24). In our experiments with canine LV, we
observed that cell capacitance declined ~25% in detubulated
myocytes, consistent with previous reports. Elimination of
the T-system caused IP in EPI to drop to the same value as
in ENDO, whereas IP in ENDO did not change. In detubu-
lated myocytes IP in EPI became insensitive to exogenous
A2. Because IP and Ito appear to be coherently regulated,
the same conclusions should apply to Ito.
If AT1R stimulation takes place within the T-system, a
significant percentage of Na/K pumps and ICaL and Ito chan-
nels must localize to the T-system membranes. Indeed, pre-
vious reports have described such localization. Localization
of the majority of plasma membrane ICa,L channels to the
T-system has been documented in rat myocytes (22). Take-
uchi et al. (27) presented evidence for high Kv4.2 localiza-
tion to the T-system of rat, although these channels were
appreciably detected in nontubular membrane as well.
Further, different isoforms of the a-subunit of the Na/K
Autocrine A2 CreatesTransmural Gradients 2371ATPase are expressed in the T-system and surface mem-
branes of rat ventricular myocytes (28). There is also a
higher density of both Na/K pumps and Na/Ca exchangers
in the T-system than in surface membranes of these
cells (29).Hypothesis 2: a transmural gradient in A2
We assayed for the effects of A2 through the thickness of
the LV wall by measuring IP and Ito in five transmural
layers. We proposed two models that could explain our
observations:
1. The affinity of AT1Rs for A2 changed from high in
ENDO to low in EPI; or
2. The concentration of A2 changed from high in ENDO to
low in EPI.
Our Fig. S1 detected no difference between ENDO and EPI
receptors, whereas Sadoshima and Izumo (9) showed auto-
crine secretion of A2 increased with strain. We therefore
adopt Model 2 as our working hypothesis, but Model 1
has not been ruled out. A2 dose-inhibition relationships
for IP and Ito were constructed using myocytes from EPI,
where AT1R activation by endogenous A2 appeared to be
essentially zero. Based on the measured inhibitions in
each region, the concentrations of endogenous A2 were
back-calculated from the dose-inhibition curves. The results
shown in Fig. 4 D indicate endogenous [A2] monotonically
decreases from ~1.4 mM in ENDO to essentially zero in
EPI. The discussion in the previous section supports the
hypothesis that these concentrations are in the lumen of
the T-system. However, if A2 is secreted into the T-system
lumen, it will also diffuse out of the T-system lumen, so
these A2 concentrations are spatial averages within each
tubule. Fig. S5 sketches the difference between exogenous
and endogenous A2.
The concentration of endogenous A2 is quantitatively
estimated by considering a simple model of a typical
T-tubule, which is assumed to be a right circular cylinder
whose length a ¼ 8 mm and radius is 0.1 mm. A2 is assumed
to be secreted uniformly by the membranes of the T-tubule.
The steady-state diffusion equation for A2 is
D
d2½A2
dx2
¼ Sm
VT
jA2;
d½A2ð0Þ
dx
¼ 0;
½A2ðaÞ ¼ 0;
(1)
where the closed end of the tubule is at x ¼ 0 and the open
end at the cell surface is at x ¼ a, the diffusion coefficient is
Dz 0.6 106 cm2/s, the surface/volume of the T-tubule is
Sm/VT z 2  105 cm1, and the rate of secretion of A2
is given by jA2 moles/(cm
2 s). The solution to Eq. 2 is½A2ðxÞ ¼ ½A2ð0Þð1 x2=a2Þ;
½A2ð0Þ ¼ Sm
VT
a2jA2
2D
:
(2)
The timescale for A2 to develop the above parabolic con-
centration profile depends on the size of the tubule and is
given by a2/D z 1 s. Thus the concentration of A2 in the
T-system can change rather quickly in comparison to the
2-h wait before whole-cell patch-clamp data were collected.
The effect of A2 on the AT1Rs and subsequent steps are
therefore rate-limiting for the development of the effect of
A2 on ICaL, IP, or Ito.
Our data indicate the average [A2] in ENDO is 1.36 mM.
Based on Eq. 3, this implies [A2] varies from [A2](0) ¼
2.0 mM to [A2](a) ¼ 0. Inserting [A2](0) ¼ 2  109
moles/cm3 into Eq. 3 gives jA2 ¼ 0.02 pmoles/(cm2 s).
Because we found the T-system capacitance per myocyte
is ~50 pF, corresponding to ~50  106 cm2 of membrane,
each myocyte is secreting A2 at the rate of ~0.01 fmole/s.
Thus, despite a fairly rapid time constant, a low rate of
secretion into a compartment as small as the T-system
lumen can generate a significant concentration of A2. This
is because the surface/volume for the T-tubule is very large.
Conversely, it would require a high rate of A2 secretion
across surface membranes to generate a significant concen-
tration at the surface of the myocyte; indeed, the rate of
secretion might generate a concentration of A2 that affected
nonspecific targets outside of the heart. Given evolution has
selected an autocrine system, one that requires extracellular
binding, the system clearly needs to be located in a small
restricted compartment, like the T-system, to regulate the
local extracellular concentration without significantly per-
turbing the global extracellular concentration. Moreover, if
the receptors in this autocrine system respond only to local
[A2] and not systemic [A2], they need to have a much lower
affinity for A2 than systemic receptors, and this is indeed the
case. Because the receptors respond to AT1R inhibitors as
normal AT1Rs, we speculate there are some posttransla-
tional modifications that have conferred the relatively low
A2-affinity.Hypothesis 3: increasing [A2] coherently reduces
Ito and IP, and increases ICaL
Coherent regulation of Ito and IP is primarily based on A2
dose-inhibition relationships (shown in Fig. 4 A). The K0.5
values of the two curves are essentially identical, suggesting
that A2 regulation involves the same mechanisms. This hy-
pothesis is also consistent with Hypothesis 5 that both trans-
porters are internalized with activated AT1Rs. With regard to
ICaL, it is larger in ENDO than EPI (21) (our data shown in
Fig. 7 B), and exogenous A2 applied for 2 h to isolated
EPI myocytes caused ICaL to increase to ENDO levels
(Fig. 7 D), but its relationship to A2 concentration is notBiophysical Journal 106(11) 2364–2374
2372 Gao et al.known. Because the transmural gradient in ICaL is opposite
to that of IP or Ito, Hypothesis 3 cannot apply to ICaL. The
mechanism, therefore, requires more steps in the signal
transduction cascade for activated, internalized AT1Rs.
Nevertheless, the existing data suggest that regulation of
ICaL through autocrine A2 is present in the T-system of these
myocytes.Hypothesis 4: A2 is secreted in response to load
and causes increased contractility
Support for the first part of this hypothesis was provided by
Sadoshima and Izumo (9), who stretched neonatal cardiac
myocytes in vitro and observed acute A2 release. Previous
reports have shown that a transmural gradient in stress
distribution and deformation exists in the LV wall, in which
mechanical strain and cell shortening are highest in ENDO
(14–16). Mechanical strain is approximately a linear func-
tion of position along the thickness of the LV wall (16), so
transmural variations in electrical properties may be gener-
ated via a linear gradient in mechanical strain-induced auto-
crine A2 secretion. Indeed, the following basic assumptions
lead to Eq. 3:
1. Autocrine secretion of A2 is a sigmoidal function of
strain developed in the ventricular wall when the cham-
ber fills with blood.
2. Strain is approximately a linear function of position
across the ventricular wall, varying from 0.2 in ENDO
to 0.06 in EPI (16).
3. There is a threshold strain, then strain could be sensed
and transduced through a series of steps to secretion
of A2.
Steps 1–3 can be lumped into a Hill equation of the form
½A2 ¼ A2N S
n
Sn þ Kn; (3)
where S is strain. Thus, while Eq. 3 is heuristic, it is consis-
tent with the results of Sadoshima and Izumo (9), suggesting
a relationship between A2 secretion and load. Our data sup-
port the idea that A2 secretion is a function of passive
stretch-tension in the myocardium during diastole (see
Eq. 3, Fig. 4 D, and related text). Autocrine A2 secretion
is higher in regions that are subjected to higher mechanical
strain.
Consistent with the strain hypothesis, previous reports
indicate that when the mouse LV is subjected to pressure
overload, transmural differences in Ito (30) are abolished
with overall reductions in Ito to ENDO levels, in tandem
with the development of cardiac hypertrophy (3,31). In
this case, it appears likely that A2 secretion increased in
all layers, but only had a significant effect in regions, such
as EPI or MID, where physiological levels of endogenous
A2 were originally low and had marginal effect in regionsBiophysical Journal 106(11) 2364–2374such as ENDO, where endogenous A2 was already satu-
rating. As a result, overall increases in A2 secretion led to
Ito reduction uniformly to ENDO levels.
The second part of this idea is that A2 causes increased
contractility. The data presented here in connection with
the results of Sadoshima and Izumo (9) suggest there is a
transmural concentration gradient in endogenous A2, which
correlates with a transmural gradient in contractility (32).
The connection between A2 and contractility is presumably
through the ion transporters that are regulated by A2, and
their effects on calcium dynamics. Higher A2 in ENDO
over EPI causes inhibition of ENDO IP, which causes
increased intracellular sodium and reduced Na/Ca exchange
and increased intracellular calcium (33), which increases
contractility. Higher A2 in ENDO also caused inhibition
of Ito. Dong et al. (34) used the dynamic clamp to introduce
Ito to the action potential in EPI myocytes, where it
increased phase-1 repolarization, reduced the amplitude of
calcium transients, and reduced contractions. Thus A2-
mediated inhibition of Ito in ENDO relative to EPI should
increase contractility in ENDO relative to EPI. The higher
ICaL in ENDO relative to EPI, first reported by Wang and
Cohen (5) and also shown here in Fig. 7 B, appears to be
due to endogenous A2. Elevated ICaL in ENDO relative
to EPI will also contribute to increased contractility in
ENDO relative to EPI. Thus all of the currents that are
known to be regulated by A2 are coherently regulated in
the direction to cause increased contractility in response to
increased A2.
If this hypothesis is correct, it implies a feedback control
system in which changes in A2 secretion are driven by the
difference between load and contractile force. When the
cells were isolated from the heart for these studies, both
load and contractions ceased to exist. Without knowing
the details of the control system, one cannot predict the
effect of cell isolation on A2 secretion. Our observation is
that secretion continued for at least 24 h, but eventually
ran down in 28–29 h (see Fig. S3). In the working heart,
where both signals are present, secretion could change
much more quickly. However, because the response appears
to require the second phase of AT1R signaling (internaliza-
tion of the receptors), the minimum response time is prob-
ably in the range of tens of minutes to 1 h.Hypothesis 5: A2-mediated inhibition of Ito and IP
is via internalization with activated AT1Rs
This idea implies the transport proteins responsible for IP
and Ito are uniformly expressed across the ventricular
wall, but those residing in membranes of the T-system are
associated with the AT1Rs. The entire T-system membrane
complex of AT1R-Na/K pumps-Kv4.3/KChIP2 is reversibly
internalized to a submembrane pool of endosomal vesicles
when the AT1Rs are activated and internalized. Kv4.3, the
a-subunit of Ito, has been shown by Western blotting to be
FIGURE 8 A simplified block diagram for feedback control of contrac-
tile force. When load is greater than force, the concentration of A2 in the
T-system lumen increases, activating AT1Rs, which initially leads to elec-
trical remodeling. If electrical remodeling is insufficient to restore balance
between load and contractile force, then anatomical remodeling eventually
occurs.
Autocrine A2 CreatesTransmural Gradients 2373uniform across the wall. However, Western blots do not
distinguish among protein in endosomal vesicle membrane,
surface membrane, or T-system membrane. Kv4.3 co-im-
munoprecipitates with AT1Rs (19), so it is likely that
Kv4.3 protein in the T-system membranes will internalize
when the AT1R is internalized.
Here we show that the Na/K pump also associates with
AT1Rs (see Fig. S2), and that blockade of AT1Rs makes
both Ito and IP uniform across the wall at their high EPI
values. This should represent the amounts expressed in
T-system plus surface membranes. Application of saturating
exogenous A2 also makes both currents uniform across the
wall, but at their low ENDO values. This should represent
the amounts expressed in surface membranes. Subtraction
gives the amounts expressed in T-system membranes. Based
on our data recorded from different groups of cells at
different times, 33–50% of IP is expressed in T-systemmem-
branes, 56–65% of Ito is expressed in T-system membranes,
and T-system membranes comprise 25% of the total plasma
membrane. Moreover, 100% of the T-system protein respon-
sible for each current can be internalized with AT1Rs.
Both Ito and IP appear to be regulated by trafficking, prob-
ably with the AT1R. Because IP and Ito are coherently
regulated, the proteins responsible for IP are probably inter-
nalized in the same signal transduction complex. Moreover,
microtubules are important in membrane trafficking. Our
previous work has shown that the effects of A2 on Ip and
Ito are eliminated in the presence of colchicine, a microtu-
bule inhibitor (20,21). Thus both currents appear to be
regulated through trafficking, and because the K0.5 for A2-
mediated inhibition is the same for both currents, they
most likely traffic together.
One corollary to this hypothesis is that the transmural
gradient in KChIP2 (35–37), the b-subunit of Ito, does not
contribute to the transmural gradient in Ito. This implies
that the amount of KChIP2 expressed in ENDO, where
KChIP2 is lowest, exceeds the amount of Kv4.3 that is ex-
pressed. Thus, the gradient in KChIP2 appears to be present
for some purpose other than transmural regulation of Ito.A possible feedback control system for A2
secretion
We should note at the outset that if Model 1 (regulation of
AT1R affinity for A2) was correct, an almost identical feed-
back system could regulate AT1R affinity. Data discussed
above suggest an overall feedback control system (Fig. 8)
that dynamically regulates contractile force in the heart.
As the ventricular chamber fills, parallel elastic elements
are stretched, and that stretch would need to be sensed.
Although there is no direct evidence that the sensor is
composed of the TRP channels, these channels are known
to be present in heart cell membranes where they respond
to stretch (38). In Fig. 8, they have been indicated with a
question mark as the sensor of parallel elastic stretch.Stretch of the cell membrane would stimulate A2 secretion.
Contractile force would also need to be sensed in the series
elastic element. Again, there is no direct evidence that Titin
Kinase is the sensor, but it is present at the Z-line of cardiac
myocytes, where it responds to stretch as the sarcomeres
contract (39), so it has been included as a candidate for
the sensor of series elastic stretch. Stretch of the series
elastic element would inhibit secretion of A2. If load and
contractile forces are in proper balance, A2 secretion would
be constant; however, if load exceeded force production,
more A2 would be secreted, causing decreases in IP and
Ito, and increases in calcium current, resulting in increases
in contractile force until balance is restored.
These changeswould be posttranslationalmodifications of
existing transport proteins, so they would occur more rapidly
than anatomical remodeling, which requires synthesis and
expression of new protein. However, if electrical remodeling
is insufficient to restore balance, A2 secretion would
continue to increase and eventually cause anatomical remod-
eling and hypertrophy to increase contractile force. All of this
is summarized in Fig. 8, which implicitly includes many
signal transduction steps, a number of which have not been
experimentally characterized, but the input-output relation-
ships are consistent with the data discussed above.SUPPORTING MATERIAL
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